Miguel Burgos

Miguel Burgos

Universidad de Castilla la Mancha - Ciudad Real / Spain
Medical and Health Sciences / Physiology
AD Scientific Index ID: 4454762
University of Castilla-La Mancha
person_outline Miguel Burgos's MOST POPULAR ARTICLES
1-) Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancerMM Noblejas-López, C Nieto-Jimenez, M Burgos, M Gómez-Juárez, ...Journal of Experimental & Clinical Cancer Research 38 (1), 1-9, 2019542019
2-) Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: modulation of cytotoxicity by nitric oxideJM Perez-Ortiz, P Tranque, M Burgos, CF Vaquero, J LlopisMolecular pharmacology 72 (2), 407-417, 2007522007
3-) CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytesS Garaud, TE Taher, M Debant, M Burgos, S Melayah, C Berthou, ...Cellular & molecular immunology 15 (2), 158-170, 2018532018
4-) Synthetic lethality interaction between aurora kinases and CHEK1 inhibitors in ovarian cancerA Alcaraz-Sanabria, C Nieto-Jimenez, V Corrales-Sanchez, ...Molecular cancer therapeutics 16 (11), 2552-2562, 2017522017
5-) Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancerE Niza, MM Noblejas-López, I Bravo, C Nieto-Jiménez, JA Castro-Osma, ...Nanomaterials 9 (12), 1793, 2019452019